PIQProteomics
About Proteomics
Proteomics (ASX:PIQ) is an Australian biotechnology company that specializes in proteomics research and services. Proteomics is the study of proteins, which are the building blocks of life. Proteomics International offers a range of proteomics services, including protein identification, quantification, and characterization. Proteomics International also develops and sells proteomics software and hardware. Proteomics International's customers include pharmaceutical companies, biotechnology companies, and academic institutions. Proteomics International's proteomics services are used in a variety of research and development applications, including drug discovery, biomarker development, and disease diagnosis.
What is PIQ known for?
Snapshot
Public AU
Ownership
2001
Year founded
32
Employees
Perth, Australia
Head office
1 of 83
AU Rank
Unknown
Sector
N/A
Sector rank
Loading Map...
Operations
All Locations
Perth, AU
Produtos e/ou serviços de Proteomics
- Protein identification: Proteomics International can identify proteins in a sample using a variety of mass spectrometry techniques.
- Protein quantification: Proteomics International can quantify proteins in a sample using a variety of techniques, including mass spectrometry and ELISA.
- Protein characterisation: Proteomics International can characterise proteins in a sample using a variety of techniques, including mass spectrometry, Western blotting, and immunoprecipitation.
- Proteomics software: Proteomics International develops and sells proteomics software, such as ProteinPilot and Scaffold.
- Proteomics hardware: Proteomics International sells proteomics hardware, such as mass spectrometers and liquid chromatography systems.
equipe executiva do Proteomics
- Dr. Richard John Lipscombe M.A., MA (Oxford), Ph.D., Ph.D., (London)Co-Founder, MD & Director
- Ms. Jacqueline GrayCFO & Head of Corporate Development
- Mr. John Chuck MorrisonHead of Business Development
- Dr. Scott BringansHead of Research
- Dr. Pearl TanHead of Product Development
- Dr. Kirsten PetersHead of Clinical Studies
- Mr. Phillip PratherChief Commercial Officer
- Mr. Timothy Luscombe B.Com., C.A.Company Secretary
- Mr. David WoodJoint Company Secretary